President Donald Trump on Friday promised that 100 million doses of Covid-19 vaccine will be manufactured by the end of 2020. He also added that the missing doses to vaccinate all Americans will be produced by April 2021 .

Donald Trump pledged on Friday that 100 million doses of Covid-19 vaccine would be manufactured before the end of the year, and enough to vaccinate 330 million Americans by April 2021.


"We will have manufactured at least 100 millions of doses before the end of the year, and then probably many more, hundreds of millions of doses will be available each month, and we will have enough vaccines for all Americans by April, "the US president said at the time. of a press conference at the White House, reiterating his optimism about the outcome of ongoing clinical trials of investigational vaccines.

>> LIVE -

Coronavirus: follow the evolution of the situation Friday, September 18

Moderna and Pfizer have contracts with the US government

He did not specify which manufacturers would be able to deliver those volumes, but two companies, Moderna and Pfizer, are in active phase 3 clinical trials of their investigational vaccines, the first awaiting results in November, the second in October.

The two have contracted with the US government to deliver hundreds of millions of doses, and US health officials have started preparations to be able to store and deliver the first doses as early as October, and within 24 hours of a possible Authorization by the Medicines Agency (FDA).

Each vaccine would be injected in two doses separated by three or four weeks.

The date of availability of an American vaccine is an issue of the campaign for the presidential election on November 3, the Democratic candidate Joe Biden having said he does not trust Donald Trump to guarantee the integrity of the scientific approval process. 

Between 20 and 25 million people vaccinated by the end of the year?

Moncef Slaoui, senior officer of Operation Warp Speed ​​in charge of vaccines, told NPR radio on September 3 that he expected a volume of doses sufficient to vaccinate between 20 and 25 million people by the end of the year.

And Centers for Disease Prevention and Control (CDC) director Robert Redfield said this week that the vaccine would likely not be available to the majority of Americans until the second or third quarter of 2021.